Dr. Agarwal's Health Care Limited (NSE:AGARWALEYE)
India · Delayed Price · Currency is INR 477.95
-4.25 (-0.88%)
Jul 31, 2026, 3:30 PM IST
Dr. Agarwal's Health Care Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 20,801 | 17,110 | 13,322 | 10,180 | 6,961 | |
Revenue Growth | 21.57% | 28.44% | 30.86% | 46.25% | 47.73% |
Cost of Revenue | 11,804 | 9,866 | 7,663 | 5,859 | 4,025 |
Gross Profit | 8,997 | 7,244 | 5,658 | 4,321 | 2,936 |
Selling, General & Admin | 810.6 | 649.6 | 503.9 | 380.15 | 238.71 |
Other Operating Expenses | 2,429 | 1,865 | 1,532 | 1,168 | 833.54 |
Operating Expenses | 6,064 | 4,945 | 3,740 | 2,881 | 2,089 |
Operating Income | 2,932 | 2,300 | 1,919 | 1,441 | 846.92 |
Interest Expense | -903.4 | -1,079 | -956.2 | -719.73 | -453.99 |
Interest & Investment Income | 122.2 | 92.3 | 80.3 | 48.48 | 32.34 |
Currency Exchange Gain (Loss) | 56.7 | -20.3 | 24.7 | -20.05 | 81.92 |
Other Non Operating Income (Expenses) | 55.1 | 69.2 | 41.8 | 28.3 | 15.57 |
EBT Excluding Unusual Items | 2,263 | 1,362 | 1,110 | 777.55 | 522.76 |
Impairment of Goodwill | - | -30.2 | - | - | - |
Gain (Loss) on Sale of Investments | 144.1 | 171.3 | 246.7 | 46.62 | - |
Gain (Loss) on Sale of Assets | 0.3 | -4.3 | 1.9 | 0.4 | -2.36 |
Other Unusual Items | 79.1 | 99.4 | 47.6 | 11.34 | 47.23 |
Pretax Income | 2,486 | 1,599 | 1,406 | 835.91 | 567.63 |
Income Tax Expense | 805 | 495.1 | 455.2 | -196.39 | 135.99 |
Earnings From Continuing Operations | 1,681 | 1,103 | 950.5 | 1,032 | 431.64 |
Minority Interest in Earnings | -349.5 | -268.8 | -119.9 | -91.33 | -54.7 |
Net Income | 1,332 | 834.6 | 830.6 | 940.97 | 376.94 |
Net Income to Common | 1,332 | 834.6 | 830.6 | 940.97 | 376.94 |
Net Income Growth | 59.59% | 0.48% | -11.73% | 149.63% | - |
Shares Outstanding (Basic) | 316 | 298 | 265 | 235 | 206 |
Shares Outstanding (Diluted) | 318 | 300 | 265 | 236 | 206 |
Shares Change | 6.19% | 13.09% | 12.46% | 14.56% | - |
EPS (Basic) | 4.21 | 2.80 | 3.14 | 4.01 | 1.83 |
EPS (Diluted) | 4.18 | 2.78 | 3.13 | 4.00 | 1.83 |
EPS Growth | 50.36% | -11.18% | -21.75% | 118.58% | - |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 710.4 | 484.8 | 1,151 | 765.33 | 940.89 |
Free Cash Flow Per Share | 2.23 | 1.62 | 4.34 | 3.25 | 4.57 |
Gross Margin | 43.25% | 42.34% | 42.48% | 42.45% | 42.18% |
Operating Margin | 14.10% | 13.44% | 14.41% | 14.15% | 12.17% |
Profit Margin | 6.40% | 4.88% | 6.24% | 9.24% | 5.42% |
Free Cash Flow Margin | 3.42% | 2.83% | 8.64% | 7.52% | 13.52% |
EBITDA | 4,692 | 3,822 | 2,972 | 2,181 | 1,396 |
EBITDA Margin | 22.55% | 22.34% | 22.31% | 21.42% | 20.06% |
D&A For EBITDA | 1,759 | 1,522 | 1,053 | 740.28 | 549.42 |
EBIT | 2,932 | 2,300 | 1,919 | 1,441 | 846.92 |
EBIT Margin | 14.10% | 13.44% | 14.41% | 14.15% | 12.17% |
Effective Tax Rate | 32.38% | 30.97% | 32.38% | - | 23.96% |
Revenue as Reported | 21,245 | 17,570 | 13,765 | 10,315 | 7,138 |